respiratori
virus
caus
diseas
human
character
abrupt
onset
symptom
studi
human
anim
model
shown
symptom
immedi
appear
day
even
week
infect
sinc
initi
symptom
manifest
viru
recognit
element
innat
immun
respons
earli
viru
replic
must
go
larg
undetect
interv
infect
emerg
symptom
call
incub
period
wide
use
clinic
score
incub
period
describ
mani
viru
infect
underli
mechan
asymptomat
phase
comprehens
document
review
studi
interact
human
pathogen
respiratori
rna
virus
host
particular
emphasi
mechan
use
virus
inhibit
immun
discuss
concept
stealth
phase
defin
time
infect
earliest
detect
inflammatori
respons
propos
stealth
phase
phenomenon
primarili
respons
suppress
symptom
incub
period
result
viral
antagon
inhibit
major
pathway
innat
immun
system
allow
extend
time
unhind
viru
replic
virus
incub
period
common
featur
infect
pathogen
virus
defin
time
infect
pathogen
onset
symptom
determin
incub
period
differ
pathogen
assist
health
author
control
track
progress
infecti
diseas
thu
limit
spread
pathogen
possibl
epidem
length
incub
period
vari
accord
infecti
agent
host
immunolog
fit
previou
immunolog
experi
human
difficult
determin
length
incub
period
sinc
exact
time
infect
usual
unknown
thorough
review
literatur
lessler
et
al
show
report
incub
period
human
respiratori
virus
rang
around
two
day
influenza
human
rhinoviru
hrv
day
measl
viru
mev
abrupt
onset
symptom
follow
infect
respiratori
virus
mark
termin
incub
period
flulik
symptom
vari
describ
patient
fever
chill
malais
myalgia
sneez
cough
runni
nose
sinu
pain
congest
headach
other
symptom
associ
secret
type
interferon
ifn
interleukin
interleukin
interleukin
tumor
necrosi
factor
macrophag
inflammatori
cytokin
symptom
may
directli
relat
viru
cytopath
effect
shed
damag
epithelium
lead
airway
obstruct
symptom
influenza
mev
hrv
infect
result
immun
respons
infect
caus
symptom
follow
respiratori
syncyti
viru
rsv
infect
controversi
appear
direct
viru
infect
immun
respons
play
role
cytokin
usual
observ
prior
tissu
damag
gener
cytotox
cell
direct
tissu
damag
caus
viru
infect
patient
treat
type
ifn
variou
ill
report
mani
flulik
symptom
without
actual
present
respiratori
viru
infect
exampl
immun
system
contribut
flulik
symptom
fact
administr
type
ifn
caus
headach
fever
mediat
cytokin
mention
mainli
one
bestunderstood
interact
immun
system
nervou
system
although
aspect
relay
signal
unknown
larg
thought
cytokin
signal
hypothalamu
via
peripher
nervou
system
increas
thermal
set
point
symptom
also
result
cross
talk
immun
system
nervou
system
sneez
mediat
trigemin
nerv
signal
relay
brain
stem
respons
histamin
secret
leukocyt
cough
mediat
vagu
nerv
larynx
result
inflammatori
respons
lower
respiratori
tract
nasal
discharg
rhinorrhoea
combin
goblet
cell
secret
gland
secret
plasma
exud
contain
dead
leukocyt
monocyt
neutrophil
observ
color
chang
yellow
green
due
granul
content
cell
mani
cytokin
chemokin
growth
factor
present
elev
level
virusinfect
lung
serum
demonstr
similar
kinet
abovement
cytokin
cellular
sourc
cytokin
still
complet
known
epitheli
hematopoiet
cell
involv
antivir
respons
take
place
infect
cell
cell
expos
viral
compon
viral
presenc
must
sens
tolllik
receptor
tlr
retino
acid
induc
gene
rigi
like
receptor
rlr
inflammasom
complex
take
part
process
special
tlr
viral
sens
recogn
dsrna
local
plasma
membran
endosom
endosom
recogn
viral
singlestrand
rna
ssrna
recogn
unmethyl
cpg
dna
bacteria
virus
evid
suggest
play
role
recognit
rsv
mev
hemagglutinin
recogn
figur
cytosol
mediat
viral
sens
rlr
includ
rigi
melanoma
differentiationassoci
gene
rigi
activ
ssrna
doubl
strand
rna
dsrna
dsrna
rigi
signal
mitochondrialassoci
protein
known
interferon
beta
promot
figur
role
third
member
rlr
famili
rna
helicas
less
understood
implic
neg
posit
regul
rigi
function
inflammasom
protein
complex
compos
number
protein
among
differ
nodlik
receptor
nlr
main
inflammasom
complex
involv
respons
rna
virus
discuss
review
inflammasom
complex
requir
gener
activ
form
cytokin
product
cytokin
requir
two
signal
signal
one
given
recognit
viral
rna
describ
lead
increas
level
cytokin
mrna
signal
two
activ
inflammasom
sens
activ
exposur
atp
dsrna
poli
c
variou
crystal
monosodium
urat
order
produc
activ
cytokin
must
cleav
part
inflammasom
complex
contain
adapt
apoptosisassoci
specklik
protein
contain
card
asc
shown
inflammasom
requir
product
influenza
infect
vivo
remain
unclear
whether
inflammasom
physic
sens
compound
recent
suggest
influenza
viru
ion
channel
caus
chang
ionic
concentr
cellular
compart
lead
activ
figur
viral
antagon
type
ifn
induct
signal
mani
pathogen
virus
abl
inhibit
host
cell
abil
detect
infect
tlr
rlr
pathway
therebi
inhibit
product
type
ifn
cytokin
virus
also
abl
inhibit
type
ifn
signal
first
indic
immun
respons
viru
infect
secret
type
ifn
type
ifn
belong
famili
cytokin
consist
one
subtyp
subtyp
also
type
iii
ifn
also
produc
quickli
infect
although
function
regul
less
studi
type
ifn
share
similar
function
exist
multipl
gene
fact
virtual
virus
encod
protein
antagon
product
respons
type
ifn
emphas
import
antivir
immun
respons
discuss
detail
later
review
type
ifn
secret
delay
vivo
day
infect
coincid
end
incub
period
transcript
regul
type
ifn
comprehens
review
short
first
type
ifn
induc
follow
viral
recognit
transcript
mrna
requir
bind
three
group
transcript
factor
regulatori
domain
ifn
promot
activ
transcript
factor
cjun
interferon
regulatori
factor
activ
factor
respons
viru
infect
induc
trigger
either
rlr
tlr
system
figur
type
ifn
signal
receptor
lead
transcript
mani
interferon
respons
gene
isg
limit
viru
replic
enhanc
immun
respons
secret
type
ifn
signal
receptor
complex
ifnar
compos
two
transmembran
protein
subunit
present
surfac
everi
nucleat
cell
sens
type
ifn
enhanc
product
type
ifn
inflammatori
cytokin
dimer
two
subunit
ifnar
lead
activ
intracellular
kinas
phosphoryl
stat
transcript
factor
lead
gener
stat
homodim
heterodim
phosphoryl
togeth
form
complex
call
interferonstimul
gene
factor
transloc
nucleu
activ
transcript
isg
figur
similarli
type
ifn
type
iii
ifn
human
includ
express
mani
cell
type
viru
infect
tlr
ligand
stimul
similar
effect
observ
type
ifn
receptor
compos
one
chain
one
chain
also
signal
jakstat
pathway
express
appear
restrict
nonhematopoiet
cell
epitheli
cell
given
mammal
evolv
sophist
detect
respons
system
viral
infect
virus
adapt
inhibit
initi
recognit
host
immun
system
antivir
respons
initi
type
ifn
signal
rapidli
amplifi
thu
great
import
viru
delay
respons
long
possibl
virus
evolv
inhibit
ifn
induct
number
way
mani
function
influenza
nonstructur
protein
recent
review
influenza
inhibit
rigi
signal
form
complex
rigi
ssrna
explain
inhibit
activ
observ
upon
infect
influenza
virus
addit
influenza
block
viru
detect
bind
dsrna
therebi
mask
detect
rigi
influenza
also
inhibit
cellular
respons
interf
process
export
cellular
mrna
paramyxovirus
abil
inhibit
ifn
review
elsewher
brief
sendai
viru
sev
mev
mump
viru
muv
virus
v
protein
block
activ
sever
v
protein
paramyxovirus
inhibit
activ
exampl
rsv
also
block
activ
rsv
block
type
ifn
induct
bind
rigi
inhibit
downstream
signal
tlr
agonist
potent
induc
cytokin
product
therefor
surpris
littl
evid
exist
inhibit
tlr
signal
pathway
virus
discuss
suggest
certain
rsv
strain
mev
inhibit
type
ifn
induct
signal
case
mev
v
protein
act
decoy
substrat
kinas
kinas
compet
evid
exist
inhibit
influenza
hrv
human
parainfluenza
viru
hpiv
figur
respiratori
paramyxovirus
inhibit
ifn
signal
pathway
c
protein
inhibit
transloc
nucleu
activ
c
protein
inhibit
phosphoryl
evid
suggest
c
protein
mev
act
inhibit
ifn
signal
respons
v
protein
mev
appear
form
complex
differ
signal
protein
ifn
respons
pathway
prevent
either
nuclear
transloc
phosphoryl
protein
rsv
block
type
ifn
respons
thought
actual
degrad
figur
mani
protein
involv
viral
recognit
type
iii
ifn
induct
type
ifn
signal
rigi
etc
type
ifn
induc
gene
block
ifn
induct
signal
viru
also
limit
enhanc
respons
infect
discuss
influenza
inhibit
detect
viru
host
therebi
prevent
product
type
ifn
cytokin
inhibit
type
ifn
product
particular
import
sinc
sens
type
ifn
neighbor
cell
gener
antivir
state
cell
limit
viru
propag
studi
describ
viral
protein
requir
respiratori
viru
antagon
limit
vitro
experi
case
due
poor
replic
antagonist
defici
virus
vivo
difficult
extrapol
observ
event
take
place
natur
infect
studi
influenza
antagon
vivo
provid
model
respiratori
viru
inhibit
innat
immun
close
examin
vivo
influenza
viru
infect
mice
show
viru
replic
lung
almost
two
day
without
induc
innat
immun
respons
defin
period
earli
undetect
viru
infect
first
sign
immun
respons
stealth
phase
group
show
protein
influenza
respons
stealth
phase
hamper
cytokin
product
vivo
infect
viru
lack
trigger
immedi
vigor
lung
inflamm
two
day
infect
compet
viru
robust
abrupt
immun
respons
initi
infect
lung
event
demarc
initi
innat
immun
lung
innat
respons
includ
product
cytokin
eg
tnfa
type
ifn
chemokin
eg
kc
recruit
divers
cell
immun
system
migrat
dendrit
cell
dc
drain
lymph
node
lead
trigger
cell
respons
abrupt
rise
chemokin
respons
recruit
mononuclear
phagocyt
granulocyt
leukocyt
site
infect
recruit
cell
play
major
role
eventu
clearanc
viru
base
sever
studi
number
possibl
mechan
immun
system
stimul
initi
inflamm
inflam
tissu
sens
danger
signal
form
factor
releas
infect
necrot
apoptot
cell
may
stimul
neighbor
cell
produc
cytokin
chemoattract
immun
cell
blood
viral
rna
releas
die
cell
may
stimul
upon
phagocytosi
plasmacytoid
dc
pdc
macrophag
cell
culmin
type
ifn
product
tlr
system
avoid
viral
antagon
rapidli
sens
viru
insid
endosom
compart
uninfect
phagocyt
culmin
type
ifn
cytokin
product
intracellular
purin
metabolit
releas
damag
cell
includ
uric
acid
atp
stimul
inflammasom
complex
cleav
intensifi
innat
respons
inflammasom
also
activ
type
ifn
product
type
ifn
upregul
protein
contain
pyrin
motif
necessari
promot
product
also
involv
signal
cascad
sinc
upregul
compon
inflammasom
complex
natur
process
virus
replic
may
contribut
culmin
stealth
phase
viral
polymeras
mani
virus
discuss
errorpron
evolut
natur
select
standpoint
properti
advantag
promot
rapid
mutat
viral
genom
avoid
recognit
adapt
immun
respons
howev
also
possibl
process
promot
mistak
viral
replic
gener
mutat
less
effici
viral
antagonist
defect
interf
viru
particl
di
may
lead
immun
recognit
shown
mice
stock
sev
high
di
content
enhanc
immun
respons
mev
vaccin
strain
induct
type
ifn
correl
high
di
content
vitro
studi
show
cell
prime
type
ifn
abl
mount
innat
respons
infect
viru
despit
viral
antagon
type
ifn
signal
transduct
turn
transcript
program
within
cell
decreas
inhibitori
effect
viral
antagonist
upon
infect
viru
replic
poorli
cell
prime
type
ifn
also
prime
cell
secret
proinflammatori
cytokin
effici
known
preexposur
dc
type
ifn
upregul
costimulatori
molecul
major
histocompat
class
ii
mhci
mhcii
molecul
improv
function
antigen
present
cell
vivo
lung
secret
cytokin
chemokin
also
promot
system
awar
viru
infect
type
ifn
signal
develop
leukocyt
memori
cell
primari
secondari
lymphoid
organ
bone
marrow
spleen
acquir
antivir
state
enhanc
function
antivir
state
thought
function
improv
cell
immun
system
infiltr
lung
type
iii
ifn
also
induc
respiratori
viru
infect
like
limit
viru
spread
epitheli
cell
therefor
type
iii
ifn
might
induc
end
stealth
phase
complement
function
type
ifn
speed
process
occur
control
abil
viru
suppress
inflamm
observ
point
immun
modul
pathogen
target
local
lung
immun
also
extern
intervent
preprogram
leukocyt
advantag
antivir
machineri
final
multifacet
inflammatori
respons
also
affect
nonhematopoiet
cell
uninfect
epitheli
cell
protect
infect
allow
vigor
respons
upon
stimul
close
contact
epitheli
border
tight
network
lung
dc
sens
virus
migrat
along
chemokin
gradient
lung
drain
mediastin
lymph
node
mln
mln
dc
trigger
prolifer
differenti
virusspecif
cell
activ
virusspecif
effector
cell
eventu
circul
back
bloodstream
recruit
respiratori
tract
termin
infect
clear
viru
studi
track
dc
migrat
lung
mln
influenza
infect
use
fluoresc
reagent
induc
unspecif
inflamm
shown
dc
migrat
lung
mln
rapidli
like
viral
antagonist
unabl
inhibit
inflamm
trigger
inflamm
induc
fluoresc
reagent
howev
inflammatori
agent
present
track
reagent
kinet
dc
migrat
lung
mln
influenza
viru
infect
quit
slow
correl
termin
stealth
phase
dc
migrat
begin
around
two
day
infect
small
number
dc
carri
viral
antigen
first
seen
mln
reach
plateau
around
day
infect
therefor
inhibit
inflamm
two
day
affect
innat
immun
also
delay
initi
adapt
immun
relationship
incub
period
influenza
viru
immun
respons
first
two
day
influenza
viru
infect
immun
respons
inact
stealth
phase
due
viral
antagon
symptom
observ
incub
period
end
symptom
abruptli
appear
two
day
infect
innat
immun
respons
becom
activ
secret
proinflammatori
cytokin
chemokin
follow
robust
infiltr
leukocyt
site
infect
dc
migrat
respiratori
tract
lung
drain
lymph
node
migrat
dc
present
viral
antigen
activ
influenza
specif
cell
six
day
infect
viru
specif
effector
cell
infiltr
lung
resolv
infect
incub
period
help
definit
describ
time
viru
infect
onset
symptom
base
new
find
propos
model
describ
mechan
delay
symptom
innat
immun
respons
like
common
almost
known
respiratori
viru
infect
figur
delay
rise
innat
immun
respons
respiratori
viru
explain
suppress
immun
viral
antagonist
vivo
stealth
phase
termin
initi
event
breakthrough
trigger
type
ifn
cytokin
serv
stimul
cell
infect
type
ifn
prime
cell
protect
viral
antagon
allow
innat
immun
respons
proceed
much
work
must
still
done
determin
factor
sequenc
event
cell
type
relev
accomplish
end
incub
period
